Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis
NCT02338427
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Amyloidosis
Interventions
OTHER:
Immunohistochemistry
OTHER:
Proteomic analysis
Sponsor
Centre Hospitalier Departemental Vendee